RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer.

MLA

Nava Rodrigues, Daniel, et al. “RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 25, no. 2, Jan. 2019, pp. 687–97. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-18-2068.

APA

Nava Rodrigues, D., Casiraghi, N., Romanel, A., Crespo, M., Miranda, S., Rescigno, P., Figueiredo, I., Riisnaes, R., Carreira, S., Sumanasuriya, S., Gasperini, P., Sharp, A., Mateo, J., Makay, A., McNair, C., Schiewer, M., Knudsen, K., Boysen, G., Demichelis, F., & de Bono, J. S. (2019). RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 25(2), 687–697. https://doi.org/10.1158/1078-0432.CCR-18-2068

Chicago

Nava Rodrigues, Daniel, Nicola Casiraghi, Alessandro Romanel, Mateus Crespo, Susana Miranda, Pasquale Rescigno, Ines Figueiredo, et al. 2019. “RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 25 (2): 687–97. doi:10.1158/1078-0432.CCR-18-2068.